Expertise in
8
conditions

Matthieu Revest

CHU Rennes
Rennes, FR 
Expertise in
8
conditions
CHU Rennes
Rennes, FR 

Overview

Matthieu Revest practices practicing medicine in Rennes, France.

Mr. Revest is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Endocarditis, Infective Endocarditis, Pneumocystis Jiroveci Pneumonia, and Brain Abscess.

He is actively involved in clinical research, co-authoring 128 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

CHU Rennes
Rennes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Prospective Study of Staphylococcus Aureus Clinical Isolates Versus Colonization: RNAs as Potential Biomarkers for Bloodstream Infections
Prospective Study of Staphylococcus Aureus Clinical Isolates Versus Colonization: RNAs as Potential Biomarkers for Bloodstream Infections
Enrollment Status: Completed
Publish Date: April 12, 2023
Intervention Type: Other
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Non-Inferiority, Multicentered, Controlled, Randomized, Double Blinded Study Investigating the Antibiotic Treatment Duration (3-day Versus 8-day) for Subjects Admitted to Emergency Services With Acute Non-severe Community Acquired Pneumonia (CAP)
A Non-Inferiority, Multicentered, Controlled, Randomized, Double Blinded Study Investigating the Antibiotic Treatment Duration (3-day Versus 8-day) for Subjects Admitted to Emergency Services With Acute Non-severe Community Acquired Pneumonia (CAP)
Enrollment Status: Unknown
Publish Date: August 14, 2017
Intervention Type: Drug, Biological, Radiation
Study Drugs: Blood Sampling/Cell Counts/ C-reactive Protein (CRP)/Biochemistry, Augmentin, Beta-Lactams
Study Phase: Phase 2
View 2 Less Clinical Trials

128 Total Publications

Adjuvant multisite bacteriophage cocktail administration as salvage treatment in a patient with a multidrug-resistant Pseudomonas aeruginosa frontal relapsing complex osteitis.
Adjuvant multisite bacteriophage cocktail administration as salvage treatment in a patient with a multidrug-resistant Pseudomonas aeruginosa frontal relapsing complex osteitis.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 25, 2026

Frequently Asked Questions about Matthieu Revest

Is Matthieu Revest a top-rated expert for Endocarditis?

MediFind is an objective health platform that identifies experts based on real-world data. Matthieu Revest is classified as an Distinguished expert for Endocarditis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Matthieu Revest participate in research or clinical trials?

Yes. Matthieu Revest has published 128 articles and abstracts on conditions like Endocarditis. You can view a list of Matthieu Revest's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Revest's expertise for a condition
ConditionClose
    View All 35 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile